SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-22-011155
Filing Date
2022-11-07
Accepted
2022-11-07 16:31:34
Documents
5
Period of Report
2022-12-13

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tnxp-def14a_121322.htm DEF 14A 153221
2 GRAPHIC proxycard001.jpg GRAPHIC 742
3 GRAPHIC proxycard002.jpg GRAPHIC 3006
4 GRAPHIC proxycard003.jpg GRAPHIC 2082
5 GRAPHIC proxycard004.jpg GRAPHIC 3013
  Complete submission text file 0001387131-22-011155.txt   167047
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36019 | Film No.: 221365923
SIC: 2834 Pharmaceutical Preparations